Cite
HARVARD Citation
Perez, T. et al. (2021). Comparison of rituximab originator (MabThera®) to biosimilar (Truxima®) in patients with multiple sclerosis. Multiple sclerosis. pp. 585-592. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Perez, T. et al. (2021). Comparison of rituximab originator (MabThera®) to biosimilar (Truxima®) in patients with multiple sclerosis. Multiple sclerosis. pp. 585-592. [Online].